DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses

By Hwee Leeeach of these authors equally contributed. A.   Suk Suh Y.   Chul Sung Y.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 473-479

Elsevier

Access to resources Recommend Favorite

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein

By Ioannou X.P.   Gomis S.M.   Karvonen B.   Hecker R.   Babiuk L.A.   van Drunen Littel-van den Hurk S.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 127-137

Elsevier

Access to resources Recommend Favorite

Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

By Kato H.   Bukawa H.   Hagiwara E.   Xin K.-Q.K.-Q.   Hamajima K.   Kawamoto S.   Sugiyama M.   Sugiyama M.   Noda E.   Nishizaki M.   Okuda K.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1151-1160

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide

By Frangione-Beebe M.   Albrecht B.   Dakappagari N.   Rose R.T.   Brooks C.L.   Schwendeman S.P.   Lairmore M.D.   Kaumaya P.T.P.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1068-1081

Elsevier

Access to resources Recommend Favorite

Flt3 ligand and conjugation to IL-1 peptide as adjuvants for a type 1, T-cell response to an HIV p17 gag vaccine

By Pisarev V.M.   Parajuli P.   Mosley R.L.   Chavez J.   Zimmerman D.   Winship D.   Talmadge J.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2358-2368

Elsevier

Access to resources Recommend Favorite